Oral Bioavailability and Drug Delivery: A Comprehensive Guide

Improve the performance and viability of newly-developed and approved drugs with this crucial guide

Bioavailability is the parameter which measures the rate and extent to which a drug reaches a user’s circulatory system depending on the method of administration. For example, intravenous administration produces a bioavailability of 100%, since the drugs are injected directly into the circulatory system; in the case of oral administration, however, bioavailability can vary widely based on factors which, if not properly understood, can result in a failure in drug development, adverse effects, and other complications. The mechanics of oral bioavailability are therefore critical aspects of drug development.

Understanding the Challenges and Barriers to Oral Bioavailability

Oral Bioavailability and Drug Delivery provides a comprehensive coverage of this subject as well as its drug development applications. Beginning with basic terminology and fundamental concepts, it provides a thorough understanding of the challenges and barriers to oral bioavailability as well as the possibilities for improving this parameter. The resulting book is an indispensable tool for drug development research.

Key Features of the Book

• Discussion questions in many chapters to facilitate comprehension
• Detailed discussion of topics including dissolution, absorption, metabolism, and more
• Real-world examples of methods in actions throughout

Target Audience

Oral Bioavailability and Drug Delivery is ideal for:

• Pharmaceutical and biotechnology scientists working in drug discovery and development
• Researchers in chemistry, biology, pharmacology, immunology, neuroscience, and other related fields
• Graduate courses in drug development and delivery

Oral Bioavailability and Drug Delivery is a must-have resource for anyone involved in the development of new drugs and drug delivery systems. With its comprehensive coverage and practical examples, it is an essential guide for improving the performance and viability of newly-developed and approved drugs.